DNER and periodontitis: These observations, in combination with previous evidence that BET inhibitors and HDACi reduce inflammation and ameliorate alveolar bone resorption in animal models of periodontitis (40, 41), identified histone acetylation as a potential target for epigenetic host modulation therapy (7).